<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04685174</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-20-OG-0143-20-CTIL</org_study_id>
    <nct_id>NCT04685174</nct_id>
  </id_info>
  <brief_title>Intraoperative NIRS of Transplanted Kidney for Prediction of Acute and Sub-acute Injury</brief_title>
  <official_title>Intraoperative Near Infrared Spectroscopy of Transplanted Kidney for Prediction of Acute and Sub-acute Kidney Injury in Transplanted Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational cohort study, designed to explore the use of NIRS in&#xD;
      kidney transplants. This study will investigate an association between measurements of intra-&#xD;
      operative NIRS and post - operative graft dysfunction as manifested in initiation of renal&#xD;
      replacement therapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Graft Failure</measure>
    <time_frame>7 days post operative</time_frame>
    <description>Initiation of renal replacement therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Graft Failure</measure>
    <time_frame>6 months post operative</time_frame>
    <description>Initiation of renal replacement therapy</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Graft Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Invos Model 5100C Cerebral/Somatic Oximeter</intervention_name>
    <description>To measure the correlation between post arterial and venous anastomoses (reperfusion) NIRS values of transplanted kidney and post-transplant graft failure as manifested in initiation of renal replacement therapy post transplant</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Kidney transplant candidates (living/ cadaver donor) at TLVMC who will consent to&#xD;
             participate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unable to give consent,&#xD;
&#xD;
          -  patients whose surgeries were aborted before transplant,&#xD;
&#xD;
          -  patients who were lost to follow up during the first 7 post-transplant days,&#xD;
&#xD;
          -  patients who suffered from surgical graft failure (vascular problems or need for re&#xD;
             exploration due to bleeding etc.)&#xD;
&#xD;
          -  No pregnant patients will participate in this study.&#xD;
&#xD;
          -  No minors will participate in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Orr Goren, Dr</last_name>
    <phone>+972527360330</phone>
    <email>org@tlvmc.gov.il</email>
  </overall_contact>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <last_update_submitted>December 24, 2020</last_update_submitted>
  <last_update_submitted_qc>December 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

